Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ipi-926
1. Patidegib
2. Ipi-926
3. 1037210-93-7
4. Ipi 926
5. Ip9 Free Base
6. Fin-5
7. Jt96fpu35x
8. Ipi-926 Free Base
9. Chembl538867
10. Ip-9
11. Patidegib (usan)
12. Patidegib [usan]
13. N-[(3r,3'r,3'as,4ar,6's,6ar,6bs,7'ar,9s,12as,12bs)-3',6',11,12b-tetramethylspiro[1,2,3,4,4a,5,6,6a,6b,7,8,10,12,12a-tetradecahydronaphtho[2,1-a]azulene-9,2'-3a,4,5,6,7,7a-hexahydro-3h-furo[3,2-b]pyridine]-3-yl]methanesulfonamide
14. N-((2s,3r,3as,3'r,4a'r,6s,6a'r,6b's,7ar,12a's,12b's)-3,6,11',12b'-tetramethyl-2',3a,3',4,4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'h,3h-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulen]-3'-yl)methanesulfonamide
15. Patidegib [usan:inn]
16. Unii-jt96fpu35x
17. Saridegib [rescinded Usan]
18. Patidegib [inn]
19. Patidegib [who-dd]
20. Schembl421999
21. Gtpl8198
22. Dtxsid40146032
23. Chebi:177425
24. Saridegib (ipi-926; Patidegib)
25. Who 9619
26. Bdbm50293788
27. Zinc43197072
28. Db12655
29. Hy-16587
30. Cs-0007501
31. D10324
32. Q15426668
33. Methanesulfonamide, N-((2s,3r,3'r,3as,4'ar,6s,6'ar,6'bs,7ar,12'as,12'bs)- 2',3',3a,4,4',4'a,5,5',6,6',6'a,6'b,7,7',7a,8',10',12',12'a,12'b-eicosahydro-3,6,11',12'b-tetramethylspiro(furo(3,2-b)pyridine-2(3h),9'(1'h)-naphth(2,1-a)azulen)-3'-yl)-
34. Methanesulfonamide, N-((2s,3r,3'r,3as,4'ar,6s,6'ar,6'bs,7ar,12'as,12'bs)-2',3',3a,4,4',4'a,5,5',6,6',6'a,6'b,7,7',7a,8',10',12',12'a,12'b-eicosahydro-3,6,11',12'b-tetramethylspiro(furo(3,2-b)pyridine-2(3h),9'(1'h)-naphth(2,1-a)azulen)-3'-yl)-
35. N-((2s,3r,3as,3''r,4a''r,6s,6a''r,6b''s,7ar,12a''s,12b''s)-3,6,11'',12b''-tetramethyl-2'',3a,3'',4,4'',4a'',5,5'',6,6'',6a'',6b'',7,7a,7'',8'',10'',12'',12a'',12b''-icosahydro-1''h,3h-spiro[furo[3,2-b]pyridine-2,9''-naphtho[2,1-a]azulene]-3''-yl)methanesulfonamide
36. N-[(3r,3'r,3'as,4ar,6's,6ar,6bs,7'ar,9s,12as,12bs)-3',6',11,12b-tetramethylspiro[1,2,3,4,4a,5,6,6a,6b,7,8,10,12,12a-tetradecahydronaphtho[2,1-a]azulene-9,2'-3a,4,5,6,7,7a-hexahydro-3h-uro[3,2-b]pyridine]-3-yl]methanesulonamide
| Molecular Weight | 504.8 g/mol |
|---|---|
| Molecular Formula | C29H48N2O3S |
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 504.33856457 g/mol |
| Monoisotopic Mass | 504.33856457 g/mol |
| Topological Polar Surface Area | 75.8 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 988 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of naevoid basal-cell carcinoma syndrome (Gorlin syndrome)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Patidegib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Patidegib, including repackagers and relabelers. The FDA regulates Patidegib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Patidegib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Patidegib supplier is an individual or a company that provides Patidegib active pharmaceutical ingredient (API) or Patidegib finished formulations upon request. The Patidegib suppliers may include Patidegib API manufacturers, exporters, distributors and traders.
Patidegib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Patidegib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Patidegib GMP manufacturer or Patidegib GMP API supplier for your needs.
A Patidegib CoA (Certificate of Analysis) is a formal document that attests to Patidegib's compliance with Patidegib specifications and serves as a tool for batch-level quality control.
Patidegib CoA mostly includes findings from lab analyses of a specific batch. For each Patidegib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Patidegib may be tested according to a variety of international standards, such as European Pharmacopoeia (Patidegib EP), Patidegib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Patidegib USP).
LOOKING FOR A SUPPLIER?
